However, assessing the need for early revascularization in patients with severe CKD remains a major challenge, as in these patients, the most sensitive biomarker to date for the diagnosis of AMI, hs-cTnT, is chronically and often nonspecifically elevated [13,14]. Here, TNNT2 is linked to chronic kidney disease.